Skip to main content
SpringerLink
Log in

FGF23 analysis of a Chinese family with autosomal dominant hypophosphatemic rickets

  • Original Article
  • Published:
Journal of Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

Autosomal dominant hypophosphatemic rickets (ADHR; MIM 193100) is a hereditary disorder characterized by isolated renal phosphate wasting, hypophosphatemia, and inappropriately normal 1,25-dihydroxyvitamin D3 levels. Recent studies have shown that the fibroblast growth factor 23 (FGF23) gene is responsible for this disease. FGF23 protein is a phosphaturic factor that is elevated in several diseases associated with hypophosphatemia and rickets but varies with disease status in ADHR. In the present study we observed a Chinese family of Han ethnic origin diagnosed with ADHR. The proband is a 30-year-old woman with no history of rickets but with multiple tooth abscesses as a young adult. She presented with progressive painful swelling of the left ankle after a blunt trauma at 26 years of age. She developed back pain, generalized weakness, and fatigue, and she could barely walk at age 27. She was found to have severe hypophosphatemia, low ratio of phosphorus tubule maximum (TmP) to glomerular filtration rate (GFR) (TmP/GFR), and elevated alkaline phosphatase at age 28. Her brother, 26 years old, presented with fatigue at 24 years of age and is normophosphatemic. The parents of this family had no history of rickets or hypophosphatemia. Direct sequence analysis of genomic DNA demonstrated a single heterozygous c.527G>A (p.R176Q) mutation in the FGF23 gene in three family members, including the proband, her brother, and their mother. Intact FGF23 assay of seven time points during the oral phosphate loading test showed no significant relationship between intact FGF23 and serum phosphorus levels of the subject with ADHR and a control. It is probably the first report of a Chinese family with ADHR.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Econs MJ, McEnery PT (1997) Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder. J Clin Endocr Metab 82:674–681

    Article  PubMed  CAS  Google Scholar 

  2. Bianchine JW, Stambler AA, Harrison HE (1971) Familial hypophosphatemic rickets showing autosomal dominant inheritance. Birth Defects Orig Artic Ser VII:287–294

    Google Scholar 

  3. Imel EAHS, Econs MJ (2007) FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets. J Bone Miner Res 22:520–526

    Article  PubMed  CAS  Google Scholar 

  4. Negri AL, Negrotti T, Alonso G, Pasqualini T (2004) Different forms of clinical presentation of an autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation in one family. Medicina (B Aires) 64:103–106

    Google Scholar 

  5. Consortium ADHR (2000) Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26:345–348

    Article  Google Scholar 

  6. White KE, Carn G, Lorenz-Depiereux B, Benet-Pages A, Strom TM, Econs MJ (2001) Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int 60:2079–2086

    Article  PubMed  CAS  Google Scholar 

  7. Bai XY, Miao D, Goltzman D, Karaplis AC (2003) The autosomal dominant hypophosphatemic rickets r176q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency. J Biol Chem 278:9843–9849

    Article  PubMed  CAS  Google Scholar 

  8. Kiela PR, Ghishan FK (2009) Recent advances in the renal–skeletal–gut axis that controls phosphate homeostasis. Lab Invest 89:7–14

    Article  PubMed  CAS  Google Scholar 

  9. Tiosano D, Hochberg Z (2009) Hypophosphatemia: the common denominator of all rickets. J Bone Miner Metab 27:392–401

    Article  PubMed  Google Scholar 

  10. Weber TJ, Liu S, Indridason OS, Quarles LD (2003) Serum FGF23 levels in normal and disordered phosphorus homeostasis. J Bone Miner Res 18:1227–1234

    Article  PubMed  CAS  Google Scholar 

  11. Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Jüppner H (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348:1656–1663

    Article  PubMed  CAS  Google Scholar 

  12. Bijvoet OL, Morgan DB, Fourman P (1969) The assessment of phosphate reabsorption. Clin Chim Acta 26:15–24

    Article  PubMed  CAS  Google Scholar 

  13. Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, Tajima T, Takeuchi Y, Fujita T, Nakahara K, Yamashita T, Fukumoto S (2002) Increased circulatory level of biologically active full-length Fgf-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 87:4957–4960

    Article  PubMed  CAS  Google Scholar 

  14. Imel EA, Peacock M, Pitukcheewanont P, Heller HJ, Ward LM, Shulman D, Kassem M, Rackoff P, Zimering M, Dalkin A, Drobny E, Colussi G, Shaker JL, Hoogendoorn EH, Hui SL, Econs MJ (2006) Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia. J Clin Endocrinol Metab 91:2055–2061

    Article  PubMed  CAS  Google Scholar 

  15. Xia W, Meng X, Jiang Y, Li M, Xing X, Pang L, Wang O, Pei Y, Yu LY, Sun Y, Hu Y, Zhou X (2007) Three novel mutations of the PHEX gene in three Chinese families with X-linked dominant hypophosphatemic rickets. Calcif Tissue Int 81:415–420

    Article  PubMed  CAS  Google Scholar 

  16. Gribaa M, Younes M, Bouyacoub Y, Korbaa W, Ben Charfeddine I, Touzi M, Adala L, Mamay O, Bergaoui N, Saad A (2009) An autosomal dominant hypophosphatemic rickets phenotype in a Tunisian family caused by a new FGF23 missense mutation. J Bone Miner Metab 28:111–115. doi:10.1007/s00774-009-0111-5

    Article  PubMed  Google Scholar 

  17. Wilson DR, York SE, Jaworski ZF, Yendt ER (1965) Studies in hypophosphatemic vitamin D-refractory osteomalacia in adults: oral phosphate supplements as an adjunct to therapy. Medicine (Baltim) 44:99–134

    CAS  Google Scholar 

  18. Harrison HE, Harrison HC, Lifshitz F, Johnson AD (1966) Growth disturbance in hereditary hypophosphatemia. Am J Dis Child 112:290–297

    PubMed  CAS  Google Scholar 

  19. Pettifor JM (2008) What’s new in hypophosphataemic rickets. Eur J Pediatr 167:493–499

    Article  PubMed  CAS  Google Scholar 

  20. Kruse K, Woelfel D, Storm TM (2001) Loss of renal phosphate wasting in a child with autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation. Horm Res 55:305–308

    Article  PubMed  CAS  Google Scholar 

  21. Yamashita T (2005) Structural and biochemical properties of fibroblast growth factor 23. Ther Apher Dial 9:313–318

    Article  PubMed  CAS  Google Scholar 

  22. Mirams M, Robinson BG, Mason RS, Nelson AE (2004) Bone as a source of FGF23: regulation by phosphate? Bone (NY) 35:1192–1199

    Article  CAS  Google Scholar 

  23. Liu S, Gupta A, Quarles LD (2007) Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization. Curr Opin Nephrol Hypertens 16:329–335

    Article  PubMed  CAS  Google Scholar 

  24. Endo I, Fukumoto S, Ozono K, Namba N, Tanaka H, Inoue D, Minagawa M, Sugimoto T, Yamauchi M, Michigami T, Matsumoto T (2008) Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients. Proposal of diagnostic criteria using FGF23 measurement. Bone (NY) 42:1235–1239

    Article  CAS  Google Scholar 

  25. Laroche M, Boyer JF, Jahafar H, Allard J, Tack I (2009) Normal FGF23 levels in adult idiopathic phosphate diabetes. Calcif Tissue Int 84:112–117

    Article  PubMed  CAS  Google Scholar 

  26. Ito N, Fukumoto S, Takeuchi Y, Takeda S, Suzuki H, Yamashita T, Fujita T (2007) Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans. J Bone Miner Metab 25:419–422

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Research funding was provided by the National Natural Science Foundation of China (NSFC) under grant No. 81070687 and the Doctoral Fund of Ministry of Education of China under grant No. 20040023055.

Author information

Authors and Affiliations

  1. Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Shuaifuyuan No. 1, Wangfujing Dongcheng District, Beijing, 100730, China

    Yue Sun, Ou Wang, Weibo Xia, Yan Jiang, Mei Li, Xiaoping Xing, Yingying Hu, Huaicheng Liu, Xunwu Meng & Xueying Zhou

  2. Department of Endocrinology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China

    Yue Sun

Authors
  1. Yue Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ou Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Weibo Xia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yan Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiaoping Xing
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yingying Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Huaicheng Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Xunwu Meng
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Xueying Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Weibo Xia.

Additional information

Y. Sun and O. Wang contributed equally to this work.

About this article

Cite this article

Sun, Y., Wang, O., Xia, W. et al. FGF23 analysis of a Chinese family with autosomal dominant hypophosphatemic rickets. J Bone Miner Metab 30, 78–84 (2012). https://doi.org/10.1007/s00774-011-0285-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00774-011-0285-5

Keywords

Search

Navigation